ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,666, issued on Aug. 11, was assigned to EDENBRIDGE PHARMACEUTICALS LLC (Parsippany, N.J.).
"Abuse-resistant pharmaceutical composition for the treatment of opioid dependence" was invented by Andreas Fischer (Uppsala, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "There is provided pharmaceutical compositions for the treatment of e.g. opioid dependency comprising microparticles of a pharmacologically-effective amount of buprenorphine, or a pharmaceutically-acceptable salt thereof, in associative admixture with particles comprising a weak acid, or particles comprising weakly-acidic buffer forming materials. The composition may further comprise ...